Filtering Through Chronic Kidney Disease: Mastering its Recognition and Management
Released On
April 25, 2024
Expires On
April 25, 2025
Media Type
Internet
Completion Time
60 minutes
Specialty
Nephrology
Topic(s)
Chronic Kidney Disease
This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Boehringer Ingelheim and Eli Lilly and Company.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 ANCC Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is intended for global primary care providers and nephrologists.
Program Overview
This enduring activity focuses on up-to-date management of CKD. Faculty will discuss strategies for earlier CKD diagnosis and provide information on current and emerging therapies. The speakers will also provide clinical practice tools that are illustrated through video cases, and discuss multidisciplinary care strategies for the comprehensive management of CKD.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Determine strategies for the early identification of CKD in patients at risk
- Assess clinical evidence on the safety and efficacy profiles of the various classes of agents used in the management of CKD
- Apply clinical guidelines when formulating management strategies for patients with CKD
- Select strategies for implementing multidisciplinary care for patients with CKD
Program Co-Chairs
Robert D. Toto, MD
Professor of Internal Medicine and Public Health
University of Texas Southwestern Medical Center
Dallas, TX
Matthew Weir, MD
Professor and Chief, Division of Nephrology
Department of Medicine, University of Maryland
School of Medicine
Baltimore, MD
Panelist
Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Henry Ford Health System
Division of Endocrinology, Diabetes, Bone Disorders
Detroit, MI
Joint Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
EACCME Credit Designation Statement
The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at [email protected].
Nursing Continuing Education Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Relevant Financial Responsibility
- Robert D. Toto, MD
- Has nothing to disclose
- Matthew Weir, MD
- Consulting Fees: Bayer, Novo Nordisk, CSL Vifor, AstraZeneca, and Boehringer-Ingelheim.
- Davida F. Kruger, MSN, APN-BC, BC-ADM
- Consulting Fees: Novo Nordisk, Lilly, Abbott, Embecta, CeQur Corporation, MannKind Corporation, Insulet, Medtronic, Ascencia & Proteomics, and Sanofi.
- Speakers Bureau: Lilly, Novo Nordisk, Dexcom, CeQur Corporation, Sanofi, and Xeris Biopharma
- Contract Research: Abbott, Beta Bionics, Insulet, NovoNordisk, and Tandem
- Stock Options (not exercised): Pendulum
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer-reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Chris Drury, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
Mike Milano, MD, has received royalties from Wolters Kluwer (Up ToDate author royalties).
Nicolas Applyrs Jr, D.O., M.S., M.P.H., has nothing to disclose.
Lauren Bartunek, Senior Program Manager for Med Learning Group, has nothing to disclose.
Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
Method of Participation
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact: Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Content - Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
